Malta - English - Medicines Authority

dr. falk pharma gmbh leinenweberstr 579108 freiburg, germany - mesalazine - suppository - mesalazine 500 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Malta - English - Medicines Authority

dr. falk pharma gmbh leinenweberstr 579108 freiburg, germany - ursodeoxycholic acid - hard capsule - ursodeoxycholic acid 250 mg - bile and liver therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - budesonide, quantity: 3 mg - capsule, enteric - excipient ingredients: sodium lauryl sulfate; purified talc; lactose monohydrate; ammonio methacrylate copolymer; methacrylic acid copolymer; titanium dioxide; erythrosine; iron oxide red; gelatin; iron oxide black; povidone; triethyl citrate; maize starch; sucrose - budenofalk enteric capsules are indicated for: induction of remission in patients with mild to moderately active crohn's disease affecting the ileum and/or the ascending colon (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; purified talc; polysorbate 80; hypromellose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; crospovidone; macrogol 6000 - treatment of chronic cholestatic liver diseases

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 50 mg/ml - oral liquid, suspension - excipient ingredients: purified water; sodium cyclamate; citric acid; sodium citrate dihydrate; xylitol; sodium chloride; glycerol; propylene glycol; benzoic acid; microcrystalline cellulose; carmellose sodium; flavour - treatment of chronic cholestatic liver diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - ursodeoxycholic acid, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; maize starch; titanium dioxide; magnesium stearate; gelatin; colloidal anhydrous silica - the treatment of chronic cholestatic liver diseases.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - budesonide - gastro-resistant granules - 9mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - budesonide - rectal foam - 2mg/1actuation

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - mesalazine - modified-release granules - 1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr. falk pharma uk ltd - mesalazine - modified-release granules - 500mg